India to Brazil: Enoxaparin Export Trade Route

The India to Brazil Enoxaparin corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $3.0M USD. The route is dominated by GLAND PHARMA LIMITED, which alone accounts for roughly 50% of all export value, reflecting the consolidated nature of India's enoxaparin manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $176.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with enoxaparin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 20.6%, placing it at rank #2 among India's top enoxaparin export destinations globally.

On the import side, key buyers of Indian enoxaparin in Brazil include Mylan Brasil Dist.De Medicamentos , MYLAN BRASIL DIST DE MEDICAMENTOS LTD, MYLAN BRASIL DIST DE MEDICAMENTOS and 3 others. Mylan Brasil Dist.De Medicamentos is the single largest importer with 6 shipments valued at $769.6K USD.

India's enoxaparin exports to Brazil are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLAND PHARMA LIMITED, GLAND PHARMA LIMITED , GLAND PHARMA LTD — together account for 100% of total trade value on this route. The average shipment value of $176.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as low molecular weight heparin enoxaparinsodium injection usp, 40mg in 0.4ml pre-filled syringe and low molecular weight heparin enoxaparinsodium injection usp 60mg in 0 6ml pre filled syringe, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, Mylan Brasil Dist.De Medicamentos is the largest importer with 6 shipments worth $769.6K USD — representing 26% of all enoxaparin imports from India on this route. A total of 6 buyers are active on this corridor.